Caroline Dubroca

661 total citations
12 papers, 438 citations indexed

About

Caroline Dubroca is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Physiology. According to data from OpenAlex, Caroline Dubroca has authored 12 papers receiving a total of 438 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Endocrinology, Diabetes and Metabolism and 5 papers in Physiology. Recurrent topics in Caroline Dubroca's work include Nitric Oxide and Endothelin Effects (4 papers), Diet, Metabolism, and Disease (3 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (2 papers). Caroline Dubroca is often cited by papers focused on Nitric Oxide and Endothelin Effects (4 papers), Diet, Metabolism, and Disease (3 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (2 papers). Caroline Dubroca collaborates with scholars based in France, United States and Russia. Caroline Dubroca's co-authors include Bernard Lévy, Daniel Henrion, Laurent Loufrani, Bruno Esposito, Sandrine Placier, Christos Chatziantoniou, Martin Flamant, Alain Tedgui, Stéphanie Lehoux and Jean‐Claude Dussaule and has published in prestigious journals such as Stroke, Hypertension and Arteriosclerosis Thrombosis and Vascular Biology.

In The Last Decade

Caroline Dubroca

11 papers receiving 433 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Caroline Dubroca France 7 172 145 82 70 63 12 438
Hiroki Fukuda Japan 14 309 1.8× 94 0.6× 62 0.8× 116 1.7× 61 1.0× 57 686
Takao Urabe Japan 9 90 0.5× 67 0.5× 76 0.9× 58 0.8× 24 0.4× 28 385
Xiuju Wu United States 11 181 1.1× 73 0.5× 65 0.8× 27 0.4× 53 0.8× 35 479
Daniela Haase Germany 12 172 1.0× 79 0.5× 44 0.5× 33 0.5× 54 0.9× 19 367
Marcello Baroni Italy 13 113 0.7× 76 0.5× 30 0.4× 31 0.4× 37 0.6× 33 472
Philipp Hillmeister Germany 11 205 1.2× 103 0.7× 70 0.9× 18 0.3× 37 0.6× 36 483
Rachael E. Redgrave United Kingdom 12 282 1.6× 117 0.8× 239 2.9× 53 0.8× 66 1.0× 18 731
Qiu-Hua Liang China 14 229 1.3× 43 0.3× 84 1.0× 28 0.4× 104 1.7× 16 557
Mar Orriols Spain 14 285 1.7× 139 1.0× 40 0.5× 23 0.3× 82 1.3× 20 635
Burçak Vural Türkiye 12 251 1.5× 71 0.5× 34 0.4× 88 1.3× 30 0.5× 38 566

Countries citing papers authored by Caroline Dubroca

Since Specialization
Citations

This map shows the geographic impact of Caroline Dubroca's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Caroline Dubroca with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Caroline Dubroca more than expected).

Fields of papers citing papers by Caroline Dubroca

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Caroline Dubroca. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Caroline Dubroca. The network helps show where Caroline Dubroca may publish in the future.

Co-authorship network of co-authors of Caroline Dubroca

This figure shows the co-authorship network connecting the top 25 collaborators of Caroline Dubroca. A scholar is included among the top collaborators of Caroline Dubroca based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Caroline Dubroca. Caroline Dubroca is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Briand, François, Caroline Dubroca, Guillaume Wettstein, et al.. (2025). Lanifibranor and semaglutide demonstrate multiple metabolic benefits in free-choice diet induced obese hamster models of MASH and MetALD. European Journal of Pharmacology. 1003. 177945–177945.
2.
3.
Тарасов, С. А., et al.. (2022). Highly Diluted Antibodies to eNOS Restore Endothelium Function in Aortic Rings From Hypertensive Rats. Dose-Response. 20(2). 1495849233–1495849233. 2 indexed citations
4.
Briand, François, Natália Martins Breyner, Thierry Lesté-Lasserre, et al.. (2021). Elafibranor improves diet-induced nonalcoholic steatohepatitis associated with heart failure with preserved ejection fraction in Golden Syrian hamsters. Metabolism. 117. 154707–154707. 23 indexed citations
5.
Briand, François, et al.. (2020). Liraglutide shows superior cardiometabolic benefits than lorcaserin in a novel free choice diet-induced obese rat model. European Journal of Pharmacology. 882. 173316–173316. 4 indexed citations
6.
Loyer, Xavier, et al.. (2019). Neuronal NO synthase mediates plenylephrine induced cardiomyocyte hypertrophy through facilitation of NFAT-dependent transcriptional activity. Biochemistry and Biophysics Reports. 18. 100620–100620. 1 indexed citations
7.
Galandrin, Ségolène, Colette Denis, Cédric Boularan, et al.. (2016). Cardioprotective Angiotensin-(1–7) Peptide Acts as a Natural-Biased Ligand at the Angiotensin II Type 1 Receptor. Hypertension. 68(6). 1365–1374. 82 indexed citations
8.
Pauw, Aurélia De, Paul Massion, Belaïd Sekkali, et al.. (2016). Paracrine nitric oxide induces expression of cardiac sarcomeric proteins in adult progenitor cells through soluble guanylyl cyclase/cyclic-guanosine monophosphate and Wnt/β-catenin inhibition. Cardiovascular Research. 112(1). 478–490. 6 indexed citations
9.
Flamant, Martin, Sandrine Placier, Caroline Dubroca, et al.. (2007). Role of Matrix Metalloproteinases in Early Hypertensive Vascular Remodeling. Hypertension. 50(1). 212–218. 145 indexed citations
10.
Dubroca, Caroline, et al.. (2005). Involvement of RhoA/Rho Kinase Pathway in Myogenic Tone in the Rabbit Facial Vein. Hypertension. 45(5). 974–979. 30 indexed citations
11.
Loufrani, Laurent, Caroline Dubroca, Zhenlin Li, et al.. (2004). Absence of Dystrophin in Mice Reduces NO-Dependent Vascular Function and Vascular Density: Total Recovery After a Treatment with the Aminoglycoside Gentamicin. Arteriosclerosis Thrombosis and Vascular Biology. 24(4). 671–676. 76 indexed citations
12.
Dubroca, Caroline, Pierre Lacombe, Valérie Domenga, et al.. (2004). Impaired Vascular Mechanotransduction in a Transgenic Mouse Model of CADASIL Arteriopathy. Stroke. 36(1). 113–117. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hiroki Fukuda Breakdown of academic impact, for papers by Takao Urabe Breakdown of academic impact, for papers by Xiuju Wu Breakdown of academic impact, for papers by Daniela Haase Breakdown of academic impact, for papers by Marcello Baroni Breakdown of academic impact, for papers by Philipp Hillmeister Breakdown of academic impact, for papers by Rachael E. Redgrave Breakdown of academic impact, for papers by Qiu-Hua Liang Breakdown of academic impact, for papers by Mar Orriols Breakdown of academic impact, for papers by Burçak Vural
Rankless by CCL
2026